GlobeNewswire - News from Maryland Contains the last 20 releases uuid:99a7fd3c-33db-4b85-aa07-ae662e902ec7;id=4853 2021-02-05T16:35:42Z newsdesk@globenewswire.com (NewsDesk) http://www.10gbhost.com/LegacyRss?Length=4 newsdesk@globenewswire.com http://www.10gbhost.com/news-release/2021/02/05/2170846/0/en/CareFirst-Launches-Better-Together-Campaign-Targeting-Necessary-COVID-19-Vaccine-Adoption.html CareFirst Launches “Better Together” Campaign Targeting Necessary COVID-19 Vaccine Adoption 2021-02-05T16:35:42Z 2021-02-05T20:08:15Z Broad community education and mobilization effort includes new public health ad, expanded resources.]]> 2170846 en GlobeNewswire Inc. CareFirst BlueCross BlueShield Fri, 05 Feb 2021 16:36 GMT Company Announcement COVID-19 CareFirst BlueCross BlueShield Coronavirus Vaccine Vaccinations Campaign Vaccine Education http://www.10gbhost.com/news-release/2021/02/05/2170765/0/en/The-Community-Financial-Corporation-Announces-Record-Results-of-1-18-Return-on-Average-Assets-for-Fourth-Quarter-2020.html The Community Financial Corporation Announces Record Results of 1.18% Return on Average Assets for Fourth Quarter 2020 2021-02-05T14:28:57Z 2021-02-05T20:08:15Z Fourth Quarter and Full Year 2020 Highlights

]]>
2170765 en GlobeNewswire Inc. The Community Financial Corporation Fri, 05 Feb 2021 14:29 GMT Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2021/02/04/2170377/0/de/Novavax-und-die-Regierung-der-Schweiz-geben-eine-Grundsatzvereinbarung-zur-Bereitstellung-des-COVID-19-Impfstoffes-bekannt.html Novavax und die Regierung der Schweiz geben eine Grundsatzvereinbarung zur Bereitstellung des COVID-19-Impfstoffes bekannt 2021-02-04T22:05:26Z 2021-02-05T20:08:15Z Die Schweiz wird sechs Millionen Dosen des Impfstoffkandidaten NVX-CoV2373 von Novavax kaufen]]> 2170377 de GlobeNewswire Inc. Novavax, Inc. Thu, 04 Feb 2021 22:05 GMT Business Contracts http://www.10gbhost.com/news-release/2021/02/04/2170335/0/en/Novavax-Announces-Start-of-Rolling-Review-by-Multiple-Regulatory-Authorities-for-COVID-19-Vaccine-Authorization.html Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization 2021-02-04T21:05:00Z 2021-02-05T20:08:15Z GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews will continue while the company completes its pivotal Phase 3 trials in the United Kingdom (U.K.) and United States (U.S.) and through initial authorization for emergency use granted under country-specific regulations.

]]>
2170335 en GlobeNewswire Inc. Novavax, Inc. Thu, 04 Feb 2021 21:10 GMT Health covid vaccine regulatory authorization
http://www.10gbhost.com/news-release/2021/02/04/2169745/0/en/Liquidity-Services-Announces-First-Quarter-Fiscal-Year-2021-Financial-Results.html Liquidity Services Announces First Quarter Fiscal Year 2021 Financial Results 2021-02-04T11:50:00Z 2021-02-05T20:08:15Z BETHESDA, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Liquidity Services (NASDAQ: LQDT; www.liquidityservices.com), the world’s largest B2B e-commerce marketplace for business and government surplus, today announced financial results for the first quarter fiscal year 2021 ended December 31, 2020. The Company's Q1-FY21 performance reflected continued customer adoption of our safe and effective e-commerce solutions across all business segments as businesses and governments seek proven digital solutions to stay competitive.

]]>
2169745 en GlobeNewswire Inc. Liquidity Services, Inc. Thu, 04 Feb 2021 11:50 GMT Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2021/02/04/2169722/0/en/Emergent-BioSolutions-to-Release-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Conduct-a-Conference-Call-on-February-18-2021.html Emergent BioSolutions to Release Fourth Quarter and Full Year 2020 Financial Results and Conduct a Conference Call on February 18, 2021 2021-02-04T11:30:00Z 2021-02-05T20:08:15Z GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 18, 2021 at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2020, recent business developments, financial outlook for full year 2021, and revenue guidance for the first quarter of 2021.

]]>
2169722 en GlobeNewswire Inc. Emergent Biosolutions, Inc. Thu, 04 Feb 2021 11:30 GMT Calendar of Events earnings invite earnings call Emergent EBS
http://www.10gbhost.com/news-release/2021/02/04/2169505/0/en/Novavax-and-Government-of-Switzerland-Announce-Agreement-in-Principle-to-Supply-COVID-19-Vaccine.html Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine 2021-02-04T02:14:20Z 2021-02-05T20:08:15Z Switzerland to purchase six million doses of the Novavax vaccine candidate, NVX-CoV2373]]> 2169505 en GlobeNewswire Inc. Novavax, Inc. Thu, 04 Feb 2021 02:14 GMT Business Contracts covid vaccine europe http://www.10gbhost.com/news-release/2021/02/04/2169502/0/en/Sensei-Biotherapeutics-Announces-Pricing-of-Upsized-Initial-Public-Offering.html Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering 2021-02-04T01:44:20Z 2021-02-05T20:08:15Z BOSTON and ROCKVILLE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the pricing of its upsized initial public offering of 7,000,052 shares of common stock at a public offering price of $19.00 per share. The gross proceeds to Sensei from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sensei, are expected to be approximately $133.0 million. All of the shares are being offered by Sensei and are expected to begin trading on The Nasdaq Global Market on February 4, 2021 under the ticker symbol “SNSE.” In addition, Sensei has granted the underwriters a 30-day option to purchase up to an additional 1,050,007 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on February 8, 2021 subject to the satisfaction of customary closing conditions.

]]>
2169502 en GlobeNewswire Inc. Sensei Biotherapeutics Thu, 04 Feb 2021 01:44 GMT Initial Public Offerings
http://www.10gbhost.com/news-release/2021/02/03/2169408/0/en/Inovalon-Reports-Fourth-Quarter-and-Full-Year-2020-Results.html Inovalon Reports Fourth Quarter and Full Year 2020 Results 2021-02-03T21:10:00Z 2021-02-05T20:08:15Z Fourth Quarter 2020 Highlights

]]>
2169408 en GlobeNewswire Inc. Inovalon Holdings, Inc. Wed, 03 Feb 2021 21:10 GMT Calendar of Events Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2021/02/03/2169254/0/en/Glen-Burnie-Bancorp-Announces-Fourth-Quarter-and-Full-Year-2020-Results.html Glen Burnie Bancorp Announces Fourth Quarter and Full Year 2020 Results 2021-02-03T15:53:23Z 2021-02-05T20:08:15Z GLEN BURNIE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Glen Burnie Bancorp (“Bancorp”) (NASDAQ: GLBZ), the bank holding company for The Bank of Glen Burnie (“Bank”), announced today a net income of $0.55 million, or $0.19 per basic and diluted common share for the three-month period ended December 31, 2020, as compared to net income of $0.54 million, or $0.19 per basic and diluted common share for the three-month period ended December 31, 2019.

]]>
2169254 en GlobeNewswire Inc. Glen Burnie Bancorp Wed, 03 Feb 2021 15:53 GMT Earnings Releases and Operating Results Maryland Earnings Finance Glen Burnie Bancorp
http://www.10gbhost.com/news-release/2021/02/03/2169150/0/en/Tenable-to-Participate-in-Upcoming-Investor-Conferences.html Tenable to Participate in Upcoming Investor Conferences 2021-02-03T14:00:00Z 2021-02-05T20:08:15Z COLUMBIA, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Tenable?, the Cyber Exposure company, today announced that its Chairman and Chief Executive Officer, Amit Yoran, and Chief Financial Officer, Steve Vintz, are scheduled to attend upcoming investor conferences.

]]>
2169150 en GlobeNewswire Inc. Tenable Holdings, Inc. Wed, 03 Feb 2021 14:00 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/03/2168967/0/en/Complete-Ethernet-Packet-Sonet-SDH-Test-Analysis.html Complete Ethernet/Packet & Sonet/SDH Test & Analysis 2021-02-03T12:17:00Z 2021-02-05T20:08:15Z (Wirespeed BERT to Protocol Analysis & Emulation up to 10 Gbps)

]]>
2168967 en GlobeNewswire Inc. GL Communications, Inc. Wed, 03 Feb 2021 12:17 GMT Product / Services Announcement Technical Analysis Ethernet Test Solutions Wirespeed BERT Protocol Analysis Packet IP Testing SONET Test Analysis SDH Test Analysis BERT Testing
http://www.10gbhost.com/news-release/2021/02/02/2168610/0/en/Tenable-Announces-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html Tenable Announces Fourth Quarter and Full Year 2020 Financial Results 2021-02-02T21:05:00Z 2021-02-05T20:08:15Z COLUMBIA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Tenable Holdings, Inc. (“Tenable”) (Nasdaq: TENB), the Cyber Exposure company, today announced financial results for the quarter and year ended December 31, 2020.

]]>
2168610 en GlobeNewswire Inc. Tenable Holdings, Inc. Tue, 02 Feb 2021 21:05 GMT Earnings Releases and Operating Results
http://www.10gbhost.com/news-release/2021/02/02/2168516/0/en/Novavax-Announces-Memorandum-of-Understanding-to-Produce-COVID-19-Vaccine-Made-in-Canada.html Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada 2021-02-02T17:31:49Z 2021-02-05T20:08:15Z GAITHERSBURG, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced memorandum of understanding with the Canadian government to produce NVX-CoV2373, the Company’s protein-based vaccine candidate against COVID-19 in Canada.

]]>
2168516 en GlobeNewswire Inc. Novavax, Inc. Tue, 02 Feb 2021 17:32 GMT Product / Services Announcement covid-19 vaccine MANUFACTURING canada
http://www.10gbhost.com/news-release/2021/02/02/2168290/0/en/Dr-Yakov-Kutsovsky-Joins-Pixelligent-Technical-Advisory-Board.html Dr Yakov Kutsovsky Joins Pixelligent Technical Advisory Board 2021-02-02T14:00:00Z 2021-02-05T20:08:15Z BALTIMORE, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Pixelligent Technologies, whose PixClear? Designer Compounds? dramatically boost the efficiency and sustainability of consumer electronics and clean energy applications, today announced that it has named Dr. Yakov Kutsovsky to the Pixelligent Technical Advisory Board.

]]>
2168290 en GlobeNewswire Inc. Pixelligent Technologies, LLC Tue, 02 Feb 2021 14:01 GMT Directors and Officers #pixelligent #augmented reality #high refractive index #nanoimprint lithography
http://www.10gbhost.com/news-release/2021/02/02/2168231/0/en/Capital-Bancorp-Announces-Approval-of-New-Stock-Repurchase-Program.html Capital Bancorp Announces Approval of New Stock Repurchase Program 2021-02-02T13:45:00Z 2021-02-05T20:08:15Z ROCKVILLE, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Capital Bancorp, Inc. (the “Company”) (NASDAQ - CBNK), the holding company for Capital Bank, NA, today announced that its Board of Directors has approved a new stock repurchase program, which authorizes the Company to repurchase up to $7.5 million?of its outstanding common stock.?

]]>
2168231 en GlobeNewswire Inc. Capital Bancorp, Inc. Tue, 02 Feb 2021 13:45 GMT Stock Market News #capitalbancorp #capitalbancorpinc #cbnk #capitalbank
http://www.10gbhost.com/news-release/2021/02/02/2168011/0/en/Cerecor-Announces-Fast-Track-Designation-for-CERC-803-for-the-Treatment-of-Leukocyte-Adhesion-Deficiency-Type-II.html Cerecor Announces Fast Track Designation for CERC-803 for the Treatment of Leukocyte Adhesion Deficiency Type II 2021-02-02T12:00:00Z 2021-02-05T20:08:15Z ROCKVILLE, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CERC-803 for the treatment of Leukocyte Adhesion Deficiency Type II (LAD-II, also known as SLC35C1-CDG). The company remains on track to initiate a pivotal trial of CERC-803 in LAD-II in?the first half of 2021 and anticipates topline data in the second half of 2021.

]]>
2168011 en GlobeNewswire Inc. Cerecor Inc. Tue, 02 Feb 2021 12:00 GMT Company Announcement
http://www.10gbhost.com/news-release/2021/02/02/2167758/0/en/Novavax-to-Present-COVID-19-Vaccine-Candidate-Data-at-New-York-Academy-of-Science.html Novavax to Present COVID-19 Vaccine Candidate Data at?New York Academy of Science 2021-02-02T00:32:50Z 2021-02-05T20:08:15Z GAITHERSBURG, Md., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn, M.D, President of Research & Development, will present on NVX-CoV2373, the company’s COVID-19 vaccine, at The New York Academy of Science (NYAS) event, ‘The Quest for a COVID-19 Vaccine.’

]]>
2167758 en GlobeNewswire Inc. Novavax, Inc. Tue, 02 Feb 2021 00:33 GMT Calendar of Events Health covid vaccine results efficacy
http://www.10gbhost.com/news-release/2021/02/01/2167651/0/en/Livanta-Earns-ISO-Re-Certification.html Livanta Earns ISO Re-Certification 2021-02-01T21:00:00Z 2021-02-05T20:08:15Z ANNAPOLIS JUNCTION, Md., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Livanta LLC (“Livanta”) announced that it has attained compliance with the International Organization for Standardization (ISO) 9001:2015 requirements for the third consecutive year, earning re-certification through December 2023. Extensive audits of the company’s operations were conducted most recently in November and December 2020, with re-certification officially confirmed on January 6, 2021. In the last three years (i.e., 2018-2020), Livanta’s ISO 9001 audits have resulted in zero negative findings. The company has continuously been recognized for developing and implementing best practices, activities, and processes to improve quality that go beyond the extensive ISO requirements. Livanta has maintained ISO 9001 certification for its quality management system since 2006.

]]>
2167651 en GlobeNewswire Inc. Livanta LLC Mon, 01 Feb 2021 21:00 GMT Company Announcement ISO Certification Standards Livanta Quality Announcement
http://www.10gbhost.com/news-release/2021/02/01/2167465/0/en/SHELLY-SPOETH-JOINS-ABT-ASSOCIATES-AS-PRINCIPAL-ASSOCIATE-COMMUNICATION-AND-BEHAVIOR-CHANGE.html SHELLY SPOETH JOINS ABT ASSOCIATES AS PRINCIPAL ASSOCIATE, COMMUNICATION AND BEHAVIOR CHANGE 2021-02-01T15:00:00Z 2021-02-05T20:08:15Z Rockville, MD, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Abt ?Associates announced today that Shelly Spoeth has joined the company as a principal associate for communication and behavior change. She will serve as a strategic communication expert ?on projects for the Centers for Disease Control and Prevention (CDC), Health Resources and Services Administration, and the Office of Infectious Disease and HIV/AIDS Policy.

]]>
2167465 en GlobeNewswire Inc. Abt Associates Mon, 01 Feb 2021 15:00 GMT Company Announcement
亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看